Dog Mast Cell Tumour Management and Welfare

Mast cell tumours are the most common malignant skin tumour in dogs. Understanding grading, treatment options, and welfare management helps owners navigate this common diagnosis.

Key Facts

Mast cell tumours account for approximately 20% of all skin tumours in dogs
Boxers, Bulldogs, Labrador Retrievers, and Golden Retrievers have higher breed predisposition
Tumour grade (low, high) determines behaviour — low-grade tumours are often curable with surgery; high-grade tumours are aggressive
Surgical excision with wide margins is the primary treatment for accessible tumours
Tyrosine kinase inhibitors (toceranib, masitinib) provide systemic treatment options for high-grade or metastatic disease
Mast cell tumour degranulation can cause local allergic reactions including swelling and redness around the tumour

Welfare Considerations

Mast cell tumour diagnosis produces significant owner anxiety, and the variable behaviour of these tumours — from easily cured lumps to aggressive metastatic disease — means prognosis communication requires care and accuracy. Dogs with high-grade disease face both physical suffering from tumour effects and the welfare costs of intensive treatment. Palliative options that maintain quality of life without aggressive intervention are important for dogs whose owners choose comfort-focused management.

What You Can Do

Have any new skin lump on your dog assessed by a vet promptly — fine needle aspirate cytology is fast and cheap
Request histopathological grading of all excised mast cell tumours to guide follow-up care
Ensure wide surgical margins are achieved — incomplete excision significantly increases recurrence risk
Discuss staging investigations including lymph node aspirate and ultrasound if high-grade disease is confirmed
Ask your vet about tyrosine kinase inhibitor treatment options for non-resectable or metastatic disease
Monitor for local degranulation reactions and seek prompt treatment if tumour manipulation causes swelling